Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
about
Mechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionSignal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their CrosstalksEpithelial-Mesenchymal Transition and Breast CancerA new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transitionMolecular mechanisms of epithelial-mesenchymal transitionTargeting the Transforming Growth Factor-β Signaling in Cancer TherapyNeuraminidase-1: a novel therapeutic target in multistage tumorigenesisIntegrins in the Spotlight of Cancer14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinA complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.STAT3 and epithelial-mesenchymal transitions in carcinomasFibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo.Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples.Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model.Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cThe need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancerUnmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study reportPTK2 rs7460 and rs7843014 polymorphisms and exceptional longevity: a functional replication study.Drug resistance in cancer: an overview.Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch.Establishment of a TGFβ-induced post-transcriptional EMT gene signature.Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.TACC3 is essential for EGF-mediated EMT in cervical cancerTGF-β signaling in breast cancer cell invasion and bone metastasis.The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.Comprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cellsRibosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating proteinDeptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expressionFAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growthβ3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells.In vivo dual substrate bioluminescent imaging.CDH2 and CDH11 act as regulators of stem cell fate decisionsSilencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cellsRhoC is essential in TGF-β1 induced epithelial-mesenchymal transition in cervical cancer cells.Hic-5 promotes invadopodia formation and invasion during TGF-β-induced epithelial-mesenchymal transition.Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue
P2860
Q26745545-797C065E-2FC6-4865-849E-F28C00B0A341Q26752554-057FD387-C5D0-48FB-B114-A593BB9A4A78Q26773055-AF37C688-A690-49F2-816E-A854D4691C4DQ26799171-C9573E38-EE1E-422E-8369-73916E44376CQ27013743-466BFCE2-AD96-46E9-BBD9-4F14C189AB13Q27021750-45DC2B64-31D4-40C4-B28C-09FCC0C365B2Q28066130-276ACB9C-D31C-41F1-8805-F075BEA5462AQ28066805-ABEDED61-CBB9-4E3D-A139-3FF7C8E91869Q28385396-1746DD7C-1D1F-4514-8B5C-5A59479BFD24Q30416855-B3B0144B-6E8F-43EF-899D-0B70F0D17ACBQ30502431-EA6FCA73-2136-4E34-A7D9-832A8A27D616Q33623947-ACE38B0B-46EB-467C-8269-7793C4C5615BQ33739802-F837A9B0-EE60-439C-A867-8246865F525EQ33759691-1694D360-CCB8-4C64-A149-1AFC48670A36Q33765924-A19A9758-65BC-4B81-AEF0-257AD1D796FCQ33859309-82843A9A-0523-418E-A67B-79F9D548FFFCQ34163763-47C52019-9EF3-4D20-8D67-AB1BCA515F7FQ34170586-E2F3BFD1-33B5-44CB-A6FE-9240B7AE2547Q34291977-3760A3E8-342F-4F53-B66C-B433FB37FD9FQ34324979-F04A0D45-8DF8-434D-BD60-DBD083A1A207Q34370851-A3B02E9A-6090-4138-8431-DCCF0A114D1CQ34437369-8E6BD822-F098-40D5-9DFB-344080437465Q34460713-153C2E57-266F-4202-B741-29E1EF460326Q34534249-4ECA1988-12C4-4889-A19F-0208FD4E5A90Q34887552-DA634535-886A-4625-8263-23BCCC6DB474Q34925509-81BB27AF-ACC6-48B5-87E7-C98D3DBD095EQ34985004-A4FC198E-EFF3-4EBD-81A7-07A64D136BEAQ35023922-F5FA5ECA-9482-4715-BEBC-5C5028152CA0Q35032720-48CDBAFE-33AA-4277-91C3-AEBB9EDFB0C8Q35053054-F103FA38-6DD7-4BFD-89C9-9A8C1F9783A1Q35214539-E7627742-1B94-43FB-A04E-4DC5F1962F43Q35532179-1F6C0AD3-BF37-4DC0-83B0-A6CE7CFE554BQ35551725-70939709-78BB-4E27-8507-AD3ADAEE3FBDQ35581797-C7E84237-80F3-48D1-B4CD-7C5BD82679D4Q35629950-3BFF480E-98DD-41AF-82E5-A1380E1AA332Q35674830-8998833E-5DCA-433B-9B7D-651A9AD86749Q35827597-64D3CAEF-B400-4C4A-9526-BE0F81D70596Q35871532-DE5C5919-7591-41DE-B3DF-74044EFA2CC1Q35925292-0BE1DBEB-79BC-41CF-B059-3835B7872DDFQ36243405-C2DC934D-F4BD-4EFF-B0CF-FB3D14F4942A
P2860
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transforming growth factor-β-i ...... dent breast cancer progression
@ast
Transforming growth factor-β-i ...... dent breast cancer progression
@en
Transforming growth factor-β-i ...... dent breast cancer progression
@nl
type
label
Transforming growth factor-β-i ...... dent breast cancer progression
@ast
Transforming growth factor-β-i ...... dent breast cancer progression
@en
Transforming growth factor-β-i ...... dent breast cancer progression
@nl
prefLabel
Transforming growth factor-β-i ...... dent breast cancer progression
@ast
Transforming growth factor-β-i ...... dent breast cancer progression
@en
Transforming growth factor-β-i ...... dent breast cancer progression
@nl
P2860
P356
P1433
P1476
Transforming growth factor-β-i ...... dent breast cancer progression
@en
P2093
W P Schiemann
P2860
P2888
P304
P356
10.1038/ONC.2010.377
P407
P577
2010-08-30T00:00:00Z
P5875
P6179
1044098922